An anticancer drug blunted atherosclerosis progression — and even made plaques shrink — in a mouse model of the disease, opening new opportunities for preventing and treating this leading cause of death.

Seven Vanderbilt University faculty members, including four from Vanderbilt University Medical Center, have been elected fellows of the American Association for the Advancement of Science.

A new tool to identify infants most at risk for severe respiratory syncytial virus (RSV) illness could aid pediatricians in prioritizing children under 1 to receive a preventive medication before RSV season (October-April).

A multicenter study led by Vanderbilt University Medical Center and Lipscomb University College of Pharmacy in Nashville has identified a potential new treatment for acute heart failure, a leading cause of hospitalization and death.

"It's been a goal and a dream for a long time," he said. "I'm grateful for the opportunity.”

The Vanderbilt Stem Cell Transplant and Cellular Therapy Symposium offers clinicians detailed information on the latest developments for hematological diseases, ranging from immunotherapies for blood cancers to new, curative therapies for sickle cell disease.

Julie Bastarache, MD, Assistant Vice President for Clinical & Translational Scientist Development at Vanderbilt University Medical Center, has been elected vice president of the American Society for Clinical Investigation (ASCI) for 2024-2025.